These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 3274452

  • 1. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 2. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 3. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 4. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC.
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract] [Full Text] [Related]

  • 5. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 6. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract] [Full Text] [Related]

  • 7. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E, Robinson C, Bear R.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract] [Full Text] [Related]

  • 8. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT, Deierhoi MH, Hudson S, Barber WH, Barger BO, Phillips MG, Diethelm AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract] [Full Text] [Related]

  • 9. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P, Squifflet JP, Pirson Y, Stoffel M, Dereme T, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract] [Full Text] [Related]

  • 10. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 11. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC, Johnson K, Richie R, Nylander W, McMahon Y, Niblack G, Green W, Morrissey J, Ynares C.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract] [Full Text] [Related]

  • 12. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M, Schleibner S, Abendroth D, Illner WD, Schneeberger H, Land W.
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract] [Full Text] [Related]

  • 13. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C, Rodriguez-Paternina E, Andrés A, Morales JM, Farias J, Montoyo C, Regueiro JR, Rodicio JL.
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract] [Full Text] [Related]

  • 15. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR, Woodle ES, Mayes JT, Stuart JK, Heffron TG, Spargo BH, Stuart FP.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract] [Full Text] [Related]

  • 16. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM, Vergne-Marini P, Langley J, Trevino G, Velez R, Brinker K, Nesser D, Long D, Hull AR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract] [Full Text] [Related]

  • 17. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 18. An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.
    Stuart FP, Stuart JK, Thistlethwaite JR, Gaber AO, Mayes J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1959-60. PubMed ID: 3152656
    [No Abstract] [Full Text] [Related]

  • 19. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM, Shen SY, Weir MR, Dagher FJ, Bentley FR.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract] [Full Text] [Related]

  • 20. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV, Andersen RC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.